ClinicalTrials.Veeva

Menu

Exogenous Ketones and Behavior (ExoKet)

G

German Institute of Human Nutrition

Status

Enrolling

Conditions

Behavior

Treatments

Dietary Supplement: dextrose (placebo)
Dietary Supplement: ketone ester

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The study will examine the effect of exogenous ketone ester on behavior and metabolism using Virtual Reality and computerizes behavioral tasks.

Full description

This study investigates the effects of exogenous ketone ester on behavior, cognition, and metabolism over one week of consumption. Using a within-subjects, randomized, crossover design, participants will undergo two phases: one with the ketone ester supplement and one with a calorie- and taste-matched placebo. The study includes four lab visits: visits 1 and 3 mark the first day of each intervention, while visits 2 and 4 mark the last day. During each visit, participants will complete behavioral tasks, questionnaires, and blood tests. Additionally, participants will record their food intake via an app and collect stool samples throughout the intervention.

Enrollment

45 estimated patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Consent to participate
  • Fluent in German
  • Physically healthy. No regular medication
  • No drug use 1 week prior to the study
  • BMI 18-31 kg/m2

Exclusion criteria

  • Former or current illnesses of:
  • Brain or mind (including eating disorders, personality disorders, alcohol, drugs or drug dependence, neurological disorders other than occasional headache; depression or anxiety disorder excluded)
  • Heart or blood circulation
  • Gastro-intestinal or endocrine disorders
  • Liver or kidney disorders
  • Electrolyte imbalance
  • Other serious past or present medical conditions (for example, metabolic syndrome, diabetes, cancer)
  • Pregnancy
  • Extreme athletes (>2h/day intense work-out; casual cycling or walking is ok)
  • Menopause (post menopause is ok)
  • Ketogenic diet, ketogenic supplement intake, intermittent fasting or calorie restricted diet during preceding 4 weeks of study participation
  • Fear of blood draw

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

45 participants in 2 patient groups, including a placebo group

ketone ester
Experimental group
Description:
Participants consume a ketone ester 3x per day for 8 days.
Treatment:
Dietary Supplement: ketone ester
Placebo containing dextrose
Placebo Comparator group
Description:
Participants consume a placebo 3x per day for 8 days. The placebo is matched in calories and taste to the ketone ester.
Treatment:
Dietary Supplement: dextrose (placebo)

Trial contacts and locations

1

Loading...

Central trial contact

Soyoung Q Park, Prof.; Beatrix Keweloh

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems